Published in PLoS Genet on March 30, 2017
A method and server for predicting damaging missense mutations. Nat Methods (2010) 78.53
An integrated encyclopedia of DNA elements in the human genome. Nature (2012) 64.73
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics (2010) 52.01
Signatures of mutational processes in human cancer. Nature (2013) 21.63
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med (2015) 13.08
A global reference for human genetic variation. Nature (2015) 12.85
Analysis of protein-coding genetic variation in 60,706 humans. Nature (2016) 11.83
COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res (2014) 10.77
Integrative analysis of 111 reference human epigenomes. Nature (2015) 10.32
Comprehensive molecular characterization of urothelial bladder carcinoma. Nature (2014) 8.48
Highly recurrent TERT promoter mutations in human melanoma. Science (2013) 8.40
DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics (2012) 4.79
Sequencing newly replicated DNA reveals widespread plasticity in human replication timing. Proc Natl Acad Sci U S A (2009) 4.76
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet (2013) 4.69
Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet (2013) 4.61
Deciphering signatures of mutational processes operative in human cancer. Cell Rep (2013) 3.61
Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature (2016) 3.05
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00
Integrative annotation of variants from 1092 humans: application to cancer genomics. Science (2013) 2.98
IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data. Bioinformatics (2012) 2.97
Identification of higher-order functional domains in the human ENCODE regions. Genome Res (2007) 2.62
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study. Lancet Oncol (2012) 2.44
The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell (2014) 2.21
Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol (2014) 2.19
LUMPY: a probabilistic framework for structural variant discovery. Genome Biol (2014) 2.17
Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. Cancer Res (2015) 1.89
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. Cancer Cell (2016) 1.79
Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcription. Oncogene (2010) 1.72
Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res (1998) 1.66
The real cost of sequencing: scaling computation to keep pace with data generation. Genome Biol (2016) 1.53
APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development. Cell Rep (2014) 1.50
Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol (2012) 1.45
Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis. Gut (2013) 1.37
FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer. Genome Biol (2014) 1.36
Differential DNA mismatch repair underlies mutation rate variation across the human genome. Nature (2015) 1.34
Thymine-DNA glycosylase and G to A transition mutations at CpG sites. Mutat Res (2000) 1.24
Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317. J Clin Oncol (2009) 1.21
PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors. Genome Biol (2015) 1.17
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Rep (2016) 1.15
NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer. Oncotarget (2015) 1.13
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma. Cancer (2015) 1.10
Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients. Int J Clin Exp Pathol (2015) 1.10
Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair. Cell (2016) 1.08
Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene (2014) 1.04
A mutational signature in gastric cancer suggests therapeutic strategies. Nat Commun (2015) 0.96
Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients. APMIS (2015) 0.92
Endogenous retroviral promoter exaptation in human cancer. Mob DNA (2016) 0.78
Landscape and variation of novel retroduplications in 26 human populations. PLoS Comput Biol (2017) 0.75
MrTADFinder: A network modularity based approach to identify topologically associating domains in multiple resolutions. PLoS Comput Biol (2017) 0.75